ALOX15
Polyunsaturated fatty acid lipoxygenase ALOX15
Also known as: 15-LOX-1, LOX15_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P16050
- Gene
- ALOX15
- Ensembl
- ENSG00000161905
- Chromosome
- 17
- Canonical length
- 662 aa
- Protein class
- Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a member of the lipoxygenase family of proteins. The encoded enzyme acts on various polyunsaturated fatty acid substrates to generate various bioactive lipid mediators such as eicosanoids, hepoxilins, lipoxins, and other molecules. The encoded enzyme and its reaction products have been shown to regulate inflammation and immunity. Multiple pseudogenes of this gene have been identified in the human genome. [provided by RefSeq, Aug 2017]
Canonical amino-acid sequenceUniProt
662 residues, UniProt reviewed canonical sequence.
>P16050|ALOX15
1 MGLYRIRVST GASLYAGSNN QVQLWLVGQH GEAALGKRLW PARGKETELK VEVPEYLGPL
61 LFVKLRKRHL LKDDAWFCNW ISVQGPGAGD EVRFPCYRWV EGNGVLSLPE GTGRTVGEDP
121 QGLFQKHREE ELEERRKLYR WGNWKDGLIL NMAGAKLYDL PVDERFLEDK RVDFEVSLAK
181 GLADLAIKDS LNVLTCWKDL DDFNRIFWCG QSKLAERVRD SWKEDALFGY QFLNGANPVV
241 LRRSAHLPAR LVFPPGMEEL QAQLEKELEG GTLFEADFSL LDGIKANVIL CSQQHLAAPL
301 VMLKLQPDGK LLPMVIQLQL PRTGSPPPPL FLPTDPPMAW LLAKCWVRSS DFQLHELQSH
361 LLRGHLMAEV IVVATMRCLP SIHPIFKLII PHLRYTLEIN VRARTGLVSD MGIFDQIMST
421 GGGGHVQLLK QAGAFLTYSS FCPPDDLADR GLLGVKSSFY AQDALRLWEI IYRYVEGIVS
481 LHYKTDVAVK DDPELQTWCR EITEIGLQGA QDRGFPVSLQ ARDQVCHFVT MCIFTCTGQH
541 ASVHLGQLDW YSWVPNAPCT MRLPPPTTKD ATLETVMATL PNFHQASLQM SITWQLGRRQ
601 PVMVAVGQHE EEYFSGPEPK AVLKKFREEL AALDKEIEIR NAKLDMPYEY LRPSVVENSV
661 AILocalizationUniProt · AlphaFold · HPA
Whether an antibody against ALOX15 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.21
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 35 nTPM
- fallopian tube: 12 nTPM
- lung: 6.2 nTPM
- small intestine: 3.2 nTPM
- breast: 3 nTPM
- pituitary gland: 2.9 nTPM
Single-cell type
- respiratory ciliated cells: 278 nCPM
- respiratory secretory cells: 143 nCPM
- respiratory deuterosomal cells: 121 nCPM
- respiratory basal cells: 120 nCPM
- mesothelial cells: 106 nCPM
- epicardial cells: 46 nCPM
Immune cell
- eosinophil: 608 nTPM
- myeloid DC: 3.1 nTPM
- plasmacytoid DC: 2.7 nTPM
- neutrophil: 1.1 nTPM
- total PBMC: 0.4 nTPM
- basophil: 0.2 nTPM
Brain region
- basal ganglia: 5.3 nTPM
- cerebral cortex: 2.9 nTPM
- hippocampal formation: 2.2 nTPM
- hypothalamus: 2.2 nTPM
- pons: 2 nTPM
- white matter: 2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.34
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.03
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic cell clearance
- arachidonate metabolic process
- bone mineralization
- cellular response to calcium ion
- cellular response to interleukin-13
- fatty acid oxidation
- hepoxilin biosynthetic process
- inflammatory response
- linoleic acid metabolic process
- lipid metabolic process
- lipid oxidation
- lipoxin A4 biosynthetic process
- lipoxygenase pathway
- long-chain fatty acid biosynthetic process
- negative regulation of adaptive immune response
- ossification
- phosphatidylethanolamine biosynthetic process
- positive regulation of actin filament polymerization
- positive regulation of cell-substrate adhesion
- positive regulation of ERK1 and ERK2 cascade
- regulation of inflammatory response
- regulation of peroxisome proliferator activated receptor signaling pathway
- response to endoplasmic reticulum stress
- wound healing
- regulation of engulfment of apoptotic cell
Molecular functions
- arachidonate 12(S)-lipoxygenase activity
- arachidonate 15-lipoxygenase activity
- iron ion binding
- linoleate 13S-lipoxygenase activity
- phosphatidylinositol-4,5-bisphosphate binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ALOX15 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ALOX15 as an antibody target. Whether an autoantibody or antibody against ALOX15 could matter depends on whether native ALOX15 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ALOX15 is annotated at the cell surface, where native ALOX15 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ALOX15 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...